US Stock MarketDetailed Quotes

C4 Therapeutics (CCCC)

Watchlist
  • 2.285
  • +0.065+2.93%
Trading Jan 16 13:30 ET
221.45MMarket Cap-1.37P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

C4 Therapeutics (CCCC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-26.90%11.23M
-46.17%6.46M
138.17%7.24M
71.44%35.58M
58.75%5.18M
38.75%15.36M
350.68%12.01M
-19.15%3.04M
-33.25%20.76M
14.26%3.26M
Operating revenue
-26.90%11.23M
-46.17%6.46M
138.17%7.24M
71.44%35.58M
58.75%5.18M
38.75%15.36M
350.68%12.01M
-19.15%3.04M
-33.25%20.76M
14.26%3.26M
Cost of revenue
Gross profit
Operating expense
-19.94%34.91M
4.53%34.96M
10.91%36.4M
-4.40%152.76M
5.40%42.89M
12.16%43.61M
-16.86%33.45M
-17.92%32.82M
-0.52%159.79M
-1.12%40.69M
Selling and administrative expenses
-24.20%8.92M
-9.57%8.77M
-9.31%9.33M
0.10%42.12M
0.74%10.37M
11.73%11.77M
-5.93%9.7M
-6.00%10.29M
-1.65%42.08M
-1.89%10.3M
-General and administrative expense
-24.20%8.92M
-9.57%8.77M
-9.31%9.33M
0.10%42.12M
0.74%10.37M
11.73%11.77M
-5.93%9.7M
-6.00%10.29M
-1.65%42.08M
-1.89%10.3M
Research and development costs
-18.37%25.99M
10.29%26.2M
20.14%27.07M
-6.01%110.64M
6.98%32.51M
12.32%31.84M
-20.63%23.75M
-22.41%22.53M
-0.11%117.71M
-0.85%30.39M
Operating profit
16.16%-23.68M
-32.92%-28.5M
2.08%-29.16M
15.72%-117.18M
-0.75%-37.71M
-1.57%-28.24M
42.92%-21.44M
17.79%-29.78M
-7.33%-139.03M
2.26%-37.43M
Net non-operating interest income expense
-37.23%2.25M
-33.41%2.48M
-26.33%2.84M
70.98%14.43M
10.75%3.27M
49.39%3.58M
126.37%3.73M
166.44%3.86M
520.97%8.44M
166.25%2.95M
Non-operating interest income
-37.23%2.25M
-33.41%2.48M
-26.33%2.84M
47.05%14.43M
10.75%3.27M
39.66%3.58M
65.89%3.73M
87.83%3.86M
174.46%9.81M
72.62%2.95M
Non-operating interest expense
----
----
----
--0
--0
--0
--0
--0
-38.04%1.37M
--0
Other net income (expense)
-10.73M
-292.43%-2.44M
0
-2.44M
-621K
0
Special income (charges)
---10.73M
--0
--0
-292.43%-2.44M
--0
--0
--0
---2.44M
---621K
--0
-Less：Restructuring and merger&acquisition
--0
--0
--0
--2.44M
--0
--0
--0
--2.44M
--0
--0
-Less:Impairment of capital assets
--10.73M
----
----
----
----
----
----
----
----
----
-Less:Other special charges
----
----
----
----
----
----
----
----
--621K
--0
Income before tax
-30.41%-32.17M
-46.87%-26.02M
7.19%-26.32M
19.84%-105.19M
0.10%-34.44M
5.25%-24.67M
50.68%-17.72M
18.46%-28.36M
-2.37%-131.21M
7.28%-34.48M
Income tax
-89.77%131K
-52.71%131K
0
0
0
1.28M
277K
Net income
-30.41%-32.17M
-46.87%-26.02M
7.19%-26.32M
20.51%-105.32M
0.52%-34.57M
8.77%-24.67M
50.68%-17.72M
18.46%-28.36M
-3.37%-132.49M
6.54%-34.75M
Net income continuous Operations
-30.41%-32.17M
-46.87%-26.02M
7.19%-26.32M
20.51%-105.32M
0.52%-34.57M
8.77%-24.67M
50.68%-17.72M
18.46%-28.36M
-3.37%-132.49M
6.54%-34.75M
Minority interest income
Net income attributable to the parent company
-30.41%-32.17M
-46.87%-26.02M
7.19%-26.32M
20.51%-105.32M
0.52%-34.57M
8.77%-24.67M
50.68%-17.72M
18.46%-28.36M
-3.37%-132.49M
6.54%-34.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-30.41%-32.17M
-46.87%-26.02M
7.19%-26.32M
20.51%-105.32M
0.52%-34.57M
8.77%-24.67M
50.68%-17.72M
18.46%-28.36M
-3.37%-132.49M
6.54%-34.75M
Basic earnings per share
-25.71%-0.44
-42.31%-0.37
9.76%-0.37
43.07%-1.52
27.94%-0.49
36.36%-0.35
64.38%-0.26
42.25%-0.41
-1.91%-2.67
10.53%-0.68
Diluted earnings per share
-25.71%-0.44
-42.31%-0.37
9.76%-0.37
43.07%-1.52
27.94%-0.49
36.36%-0.35
64.38%-0.26
42.25%-0.41
-1.91%-2.67
10.53%-0.68
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -26.90%11.23M-46.17%6.46M138.17%7.24M71.44%35.58M58.75%5.18M38.75%15.36M350.68%12.01M-19.15%3.04M-33.25%20.76M14.26%3.26M
Operating revenue -26.90%11.23M-46.17%6.46M138.17%7.24M71.44%35.58M58.75%5.18M38.75%15.36M350.68%12.01M-19.15%3.04M-33.25%20.76M14.26%3.26M
Cost of revenue
Gross profit
Operating expense -19.94%34.91M4.53%34.96M10.91%36.4M-4.40%152.76M5.40%42.89M12.16%43.61M-16.86%33.45M-17.92%32.82M-0.52%159.79M-1.12%40.69M
Selling and administrative expenses -24.20%8.92M-9.57%8.77M-9.31%9.33M0.10%42.12M0.74%10.37M11.73%11.77M-5.93%9.7M-6.00%10.29M-1.65%42.08M-1.89%10.3M
-General and administrative expense -24.20%8.92M-9.57%8.77M-9.31%9.33M0.10%42.12M0.74%10.37M11.73%11.77M-5.93%9.7M-6.00%10.29M-1.65%42.08M-1.89%10.3M
Research and development costs -18.37%25.99M10.29%26.2M20.14%27.07M-6.01%110.64M6.98%32.51M12.32%31.84M-20.63%23.75M-22.41%22.53M-0.11%117.71M-0.85%30.39M
Operating profit 16.16%-23.68M-32.92%-28.5M2.08%-29.16M15.72%-117.18M-0.75%-37.71M-1.57%-28.24M42.92%-21.44M17.79%-29.78M-7.33%-139.03M2.26%-37.43M
Net non-operating interest income expense -37.23%2.25M-33.41%2.48M-26.33%2.84M70.98%14.43M10.75%3.27M49.39%3.58M126.37%3.73M166.44%3.86M520.97%8.44M166.25%2.95M
Non-operating interest income -37.23%2.25M-33.41%2.48M-26.33%2.84M47.05%14.43M10.75%3.27M39.66%3.58M65.89%3.73M87.83%3.86M174.46%9.81M72.62%2.95M
Non-operating interest expense --------------0--0--0--0--0-38.04%1.37M--0
Other net income (expense) -10.73M-292.43%-2.44M0-2.44M-621K0
Special income (charges) ---10.73M--0--0-292.43%-2.44M--0--0--0---2.44M---621K--0
-Less：Restructuring and merger&acquisition --0--0--0--2.44M--0--0--0--2.44M--0--0
-Less:Impairment of capital assets --10.73M------------------------------------
-Less:Other special charges ----------------------------------621K--0
Income before tax -30.41%-32.17M-46.87%-26.02M7.19%-26.32M19.84%-105.19M0.10%-34.44M5.25%-24.67M50.68%-17.72M18.46%-28.36M-2.37%-131.21M7.28%-34.48M
Income tax -89.77%131K-52.71%131K0001.28M277K
Net income -30.41%-32.17M-46.87%-26.02M7.19%-26.32M20.51%-105.32M0.52%-34.57M8.77%-24.67M50.68%-17.72M18.46%-28.36M-3.37%-132.49M6.54%-34.75M
Net income continuous Operations -30.41%-32.17M-46.87%-26.02M7.19%-26.32M20.51%-105.32M0.52%-34.57M8.77%-24.67M50.68%-17.72M18.46%-28.36M-3.37%-132.49M6.54%-34.75M
Minority interest income
Net income attributable to the parent company -30.41%-32.17M-46.87%-26.02M7.19%-26.32M20.51%-105.32M0.52%-34.57M8.77%-24.67M50.68%-17.72M18.46%-28.36M-3.37%-132.49M6.54%-34.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -30.41%-32.17M-46.87%-26.02M7.19%-26.32M20.51%-105.32M0.52%-34.57M8.77%-24.67M50.68%-17.72M18.46%-28.36M-3.37%-132.49M6.54%-34.75M
Basic earnings per share -25.71%-0.44-42.31%-0.379.76%-0.3743.07%-1.5227.94%-0.4936.36%-0.3564.38%-0.2642.25%-0.41-1.91%-2.6710.53%-0.68
Diluted earnings per share -25.71%-0.44-42.31%-0.379.76%-0.3743.07%-1.5227.94%-0.4936.36%-0.3564.38%-0.2642.25%-0.41-1.91%-2.6710.53%-0.68
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.60%
Sample Name
Sample Code
 +3.67%
Sample Name
Sample Code
 +3.32%
4
Block
XYZ
+1.52%
5
Microsoft
MSFT
+1.24%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.49%
Sample Name
Sample Code
 +10.29%
Sample Name
Sample Code
 +9.49%
4
Kingsoft Cloud
KC
+6.94%
5
United Microelectronics
UMC
+6.20%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -